Avilamycin did not play a role in the discontinuation of evernimicin as a clinical drug candidate

被引：4

作者：

Belanger, AE ^{[1
]}

Shryock, TR ^{[1
]}

机构：

[1] Elanco Anim Hlth, Greenfield, IN 46140 USA

来源：

JOURNAL OF MASS SPECTROMETRY | 2005年 / 40卷 / 08期

关键词：

D O I：

10.1002/jms.889

中图分类号：

Q5 [生物化学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页码：1109 / 1109

页数：1

共 10 条

[1] Association between decreased susceptibility to a new antibiotic for treatment of human diseases, everninomicin (SCH 27899), and resistance to an antibiotic used for growth promotion in animals, avilamycin [J].

Aarestrup, FM .

MICROBIAL DRUG RESISTANCE, 1998, 4 (02) :137-141

[2] Incidence of high-level evernimicin resistance in Enterococcus faecium among food animals and humans [J].

Aarestrup, FM ;

McNicholas, PM .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (09) :3088-3090

[3] Will avilamycin convert Ziracine into zerocine? [J].

Courvalin, P .

EMERGING INFECTIOUS DISEASES, 2000, 6 (05) :558-558

[4] The antibiotic food-chain gang [J].

Courvalin, P .

EMERGING INFECTIOUS DISEASES, 2001, 7 (03) :489-490

[5] Fragmentation studies on the antibiotic avilamycin A using ion trap mass spectrometry [J].

Eichhorn, P ;

Pérez, S ;

Bechtholt, A ;

Aga, DS .

JOURNAL OF MASS SPECTROMETRY, 2004, 39 (12) :1541-1553

[6] In vitro Gram-positive antimicrobial activity of evernimicin (SCH 27899), a novel oligosaccharide, compared with other antimicrobials:: a multicentre international trial [J].

Jones, RN ;

Hare, RS ;

Sabatelli, FJ .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 47 (01) :15-25

[7] In vitro susceptibility to everninomycin of gram-positive nosocomial pathogens isolated from intensive care units in Germany [J].

Kropec, A ;

Frank, U ;

Jonas, D ;

Thriene, W ;

Schmidt-Eisenlohr, E ;

Daschner, FD .

CHEMOTHERAPY, 2001, 47 (01) :15-18

[8] Occurrence and antimicrobial susceptibility patterns of pathogens isolated from skin and soft tissue infections: report from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 2000) [J].

Rennie, RP ;

Jones, RN ;

Mutnick, AH .

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2003, 45 (04) :287-293

[9] Antimicrobial susceptibility patterns of enterococci causing infections in Europe [J].

Schouten, MA ;

Voss, A ;

Hoogkamp-Korstanje, JAA .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (10) :2542-2546

[10] Will avilamycin convert ziracine into zerocine? [J].

Shryock, TR .

EMERGING INFECTIOUS DISEASES, 2001, 7 (03) :488-489

← 1 →